Glioblastoma Bystander Cell Therapy: Improvements in Treatment and Insights into the Therapy Mechanisms

A preclinical model of glioblastoma (GB) bystander cell therapy using human adipose mesenchymal stromal cells (hAMSCs) is used to address the issues of cell availability, quality, and feasibility of tumor cure. We show that a fast proliferating variety of hAMSCs expressing thymidine kinase (TK) has...

Descripción completa

Detalles Bibliográficos
Autores principales: Guerra-Rebollo, Marta, Nogueira de Moraes, Carolina, Alcoholado, Cristina, Soler-Botija, Carolina, Sanchez-Cid, Lourdes, Vila, Olaia F., Meca-Cortés, Oscar, Ramos-Romero, Sara, Rubio, Nuria, Becerra, José, Blanco, Jeronimo, Garrido, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197388/
https://www.ncbi.nlm.nih.gov/pubmed/30364660
http://dx.doi.org/10.1016/j.omto.2018.09.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6197388/
https://www.ncbi.nlm.nih.gov/pubmed/30364660
http://dx.doi.org/10.1016/j.omto.2018.09.002

Ejemplares similares